SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales surged to Rs. 48803.00 millions, up 27.64% for the September 2022 quarter as against Rs. 38234.00 millions during the corresponding quarter previous year.The company almost doubled its revenue to Rs. 11163.00 millions  from Rs. 4490.00 millions in the quarter ended September 2022.Operating Profit saw a handsome growth to 19208.00 millions from 8664.00 millions in the quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 48803.00 38234.00 27.64 85109.00 72569.00 17.28 144052.00 133491.00 7.91
Other Income 1180.00 1181.00 -0.08 5214.00 3043.00 71.34 4820.00 8011.00 -39.83
PBIDT 19208.00 8664.00 121.70 29037.00 16145.00 79.85 30761.00 39379.00 -21.88
Interest 17.00 111.00 -84.68 115.00 176.00 -34.66 380.00 467.00 -18.63
PBDT 19191.00 8553.00 124.38 28922.00 15969.00 81.11 30381.00 38912.00 -21.92
Depreciation 2262.00 2066.00 9.49 4477.00 4037.00 10.90 8143.00 8350.00 -2.48
PBT 16929.00 6487.00 160.97 24445.00 11932.00 104.87 22238.00 30562.00 -27.24
TAX 5766.00 1997.00 188.73 8287.00 3308.00 150.51 6006.00 8698.00 -30.95
Deferred Tax 2790.00 841.00 231.75 3953.00 1168.00 238.44 2080.00 3297.00 -36.91
PAT 11163.00 4490.00 148.62 16158.00 8624.00 87.36 16232.00 21864.00 -25.76
Equity 832.00 832.00 0.00 832.00 832.00 0.00 832.00 832.00 0.00
PBIDTM(%) 39.36 22.66 73.69 34.12 22.25 53.35 21.35 29.50 -27.61

Dr. Reddys Labs. Share Price

1350.00 21.65 (1.63%)
25-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.15
Dr. Reddys Labs. 1350.00
Cipla 1440.30
Zydus Lifesciences 1101.50
Lupin 2342.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: